Sentinel Node With Ultrasound Contrast in Melanoma

This study has been completed.
Information provided by:
Rigshospitalet, Denmark Identifier:
First received: August 29, 2006
Last updated: June 17, 2008
Last verified: June 2008

The purpose is to evaluate,in 20 patients, if the sentinel node(s) in melanoma can be detected by lymph contrast ultrasound. In comparing the patients will also get lymph-scintigraphy and sentinel node detection wiht blue dye.

The goal is to improve the method for detecting sentinel node(s) in melanoma.

Condition Intervention
Malignant Melanoma
Drug: ultrasound contrast

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind
Primary Purpose: Diagnostic
Official Title: Sentinel Node Diagnostics With Ultrasound Contrast in Melanoma

Resource links provided by NLM:

Further study details as provided by Rigshospitalet, Denmark:

Estimated Enrollment: 20
Study Start Date: August 2006
Estimated Study Completion Date: April 2008
Estimated Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Malignant melanoma on a extremity,
  • No spread of the cancer,
  • Patients over 18 years old,

Exclusion Criteria:

  • Pregnancy,
  • Lactating,
  • Severe hart disease,
  Contacts and Locations
Please refer to this study by its identifier: NCT00370136

Copenhagen univercity hospital, Department of Radiology, section of ultrasound
Copenhagen, Denmark, 2100
Sponsors and Collaborators
Rigshospitalet, Denmark
Principal Investigator: Michael B Nielsen, MDSc Department of Radiology, section ultrasound
  More Information

No publications provided Identifier: NCT00370136     History of Changes
Other Study ID Numbers: (KF)01288200
Study First Received: August 29, 2006
Last Updated: June 17, 2008
Health Authority: Denmark: The Danish National Committee on Biomedical Research Ethics

Additional relevant MeSH terms:
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms, Nerve Tissue
Nevi and Melanomas processed this record on April 20, 2014